News
Live Science on MSN4h
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.
A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations ...
A measles outbreak in the state has not stopped “medical freedom” activists from pushing forward with their goal. They now ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive ...
But the political situation has changed for the ... vaccines today are placebo-tested (including the original covid-19 vaccines), it’s unclear whether this order will also apply to vaccines ...
New FDA framework on changes coronavirus vaccine approval will be released “in the coming days,” FDA Commissioner Marty ...
As of April 26, about 14% of pregnant women and 13% of children had received the updated COVID vaccine, according to the CDC.
By Kamal Choudhury (Reuters) -Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback